Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
- Conditions
- Leber Congenital Amaurosis (LCA)Retinitis Pigmentosa (RP)
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2016-04-29
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT02575430
- Locations
- ๐บ๐ธ
Wilmer Eye Institute - Johns Hopkins Hospital, Baltimore, Maryland, United States
๐บ๐ธCasey Eye Institute - Marquam Hill, Portland, Oregon, United States
๐จ๐ฆThe Hospital for Sick Children, Ophthalmology and Vision Sciences, Toronto, Ontario, Canada
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT01999764
- Locations
- ๐บ๐ธ
Proliance Surgeons Inc., Seattle, Washington, United States
๐บ๐ธOphthalmic Consultants of Boston, Boston, Massachusetts, United States
๐บ๐ธRetina Foundation of the Southwest, Dallas, Texas, United States
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
- First Posted Date
- 2012-03-05
- Last Posted Date
- 2014-12-15
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT01543906
- Locations
- ๐จ๐ฆ
Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada
๐ฎ๐ชRoyal Victoria Eye and Ear Hospital, Dublin, Ireland
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
- Conditions
- RP (Retinitis Pigmentosa)LCA (Leber Congenital Amaurosis)
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2014-07-28
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT01521793
- Locations
- ๐บ๐ธ
The Chicago Lighthouse (University of Illinois at Chicago, Pangere Center for Inherited Retinal Disease), Chicago, Illinois, United States
๐บ๐ธWilmer Eye Institute (Johns Hopkins University), Baltimore, Maryland, United States
๐จ๐ฆMontreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
- Conditions
- LCA (Leber Congenital Amaurosis)RP (Retinitis Pigmentosa)
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT01014052
- Locations
- ๐ฉ๐ช
Institute for Ophthalmic Research, University of Tubingen, Tubingen, Germany
๐จ๐ฆMontreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada
๐ฌ๐งMoorefield Eye Hospital, London, United Kingdom
Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers
- Conditions
- Healthy Human Volunteers
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2009-03-30
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00765427
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
- Conditions
- Choroidal NeovascularizationMacular Degeneration
- Interventions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2011-06-02
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 162
- Registration Number
- NCT00492284
- Locations
- ๐บ๐ธ
Retina Centers, PC, Tucson, Arizona, United States
A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
- Conditions
- End Stage Renal Disease
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2011-04-04
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT00381602
- Locations
- ๐บ๐ธ
Tulane University Medical School, New Orleans, Louisiana, United States
๐บ๐ธMayo Clinic, Rochester, Minnesota, United States
Visudyneยฎ in Occult (VIO)
- Conditions
- Macular Degeneration
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2005-07-21
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 364
- Registration Number
- NCT00121407
Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
- Conditions
- Prostatic Hyperplasia
- First Posted Date
- 2005-06-30
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- QLT Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT00116571
- Locations
- ๐บ๐ธ
Devine Tidewater Urology, Virginia Beach, Virginia, United States
๐จ๐ฆCan-Med Clinical Research Inc, Victoria, British Columbia, Canada
๐บ๐ธAccuMed Research Associates, Garden City, New York, United States